{"id":125267,"name":"ALLIANCE FOR REGENERATIVE MEDICINE","slug":"alliance-for-regenerative-medicine","state":"DC","description":"Advocacy organization supporting advances in regenerative medicine.","totalSpending":1480000,"filings":26,"yearlySpending":[{"year":2018,"income":250000},{"year":2019,"income":150000},{"year":2020,"income":150000},{"year":2021,"income":200000},{"year":2022,"income":280000},{"year":2023,"income":360000},{"year":2024,"income":90000}],"firms":["HOLLAND & KNIGHT LLP"],"lobbyists":["MICHAEL WERNER","MIRANDA FRANCO","ETHAN JORGENSEN-EARP","ISABEL LANE","MARISSA SERAFINO","JODI CHANDLER","PAOLO MASTRANGELO"],"issues":["HCR","MMM",null],"sampleDescriptions":["Implementation of 21st Century Cures regenerative medicine provisions; H.R. 2430, S. 204, Trickett Wendler Right to Try Act; other FDA-related issues.","Implementation of 21st Century Cures regenerative medicine provisions; H.R. 2430, S. 204, Trickett Wendler Right to Try Act; other FDA and CMS-related issues.","Implementation of 21st Century Cures regenerative medicine provisions; regulatory and reimbursement issues.","Implementation of 21st Century Cures regenerative medicine provisions; regulatory and reimbursement issues; value-based arrangements draft legislation.","Implementation of 21st Century Cures regenerative medicine provisions; regulatory and reimbursement issues; \"Value Based Payment\" draft legislation.","Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; regulatory reimbursement issues; \"Value Based Payment\" draft legislation.","Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; regulatory reimbursement issues; \"Value Based Payment\" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act.","Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; \"Value Based Payment\" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act.; Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Cures 2.0 legislative discussions.","Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; \"Value Based Payment\" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Cures 2.0 legislative discussions.","Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; \"Value Based Payment\" draft legislation; Cures 2.0 legislative discussions.","Value Based Payment\" draft legislation; Cures 2.0 legislative discussions.","Value Based Payment legislation; Cures 2.0 legislation; CMS policies regarding Value Based legislation; FDA appropriations.","Value Based Payment legislation; Cures 2.0 legislation; CMS policies regarding Value Based legislation; FDA user fee legislation.","Value Based Payment legislation; Cures 2.0 legislation; CMS policies regarding Value Based legislation; FDA user fee legislation; H.R. 7667, Food and Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7389, the Medicaid VBPs for Patients (MVP) Act.","Value Based Payment legislation; Cures 2.0 legislation; CMS policies regarding Value Based legislation; FDA user fee legislation; H.R. 7667, Food and Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.","CMS policies regarding Value Based legislation; FDA user fee legislation; H.R. 7667, Food and Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7389, the Medicaid VBPs for Patients (MVP) Act.","CMS policies regarding Value Based legislation; FDA user fee legislation; H.R. 7667, Food and Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.","CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666)."],"years":[2018,2019,2020,2021,2022,2023,2024]}